On the Interdisciplinary Treatment and Management of Patients with Immune-Mediated Inflammatory Diseases. A Study on Patients' Personal Experiences and Perspectives
Kasper Fjellhaugen Hjuler,Louise Møller,Cathrine Elgaard,Laura Gaïni,Lars Iversen,Tirill Hjuler
DOI: https://doi.org/10.2147/jmdh.s432820
2024-05-28
Journal of Multidisciplinary Healthcare
Abstract:Kasper Fjellhaugen Hjuler, 1, 2 Louise Faurskov Møller, 2, 3 Cathrine Dawn Büttner Elgaard, 2, 3 Laura Gaïni, 4 Lars Iversen, 2, 3 Tirill Fjellhaugen Hjuler 5 1 Department of Dermatology, Aalborg University Hospital, Aalborg, Denmark; 2 Danish National Centre for Autoimmune Diseases, Aarhus University Hospital, Aarhus, Denmark; 3 Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark; 4 Institute of Psychology, Aarhus University, Aarhus, Denmark; 5 Department of Child and Adolescent Psychiatry, Aarhus University Hospital, Aarhus, Denmark Correspondence: Kasper Fjellhaugen Hjuler, Department of Dermatology, Aalborg University Hospital, Mølleparkvej 4, Aalborg, DK-9000, Denmark, Tel +4531244813, Email Purpose: Immune-mediated inflammatory diseases (eg, axial spondylitis, psoriasis, psoriatic arthritis, Crohn's disease, ulcerative colitis, and hidradenitis suppurativa) are common diseases that exert an extensive effect on the health-related quality of life, particularly when multiple concomitant conditions are present. Previous reports indicate that the traditional siloed approach to care can lead to a lack of patient centricity and inefficient disease management. In this article, we aimed to evaluate an interdisciplinary program for the treatment of immune-mediated inflammatory diseases compared to routine clinical practice. Patients and Methods: This was a mixed-method study, combining qualitative and quantitative data. Patients with co-occurrence of ≥ 2 immune-mediated inflammatory diseases treated in an interdisciplinary clinic (n = 48) or traditional usual care (n = 17) answered open-ended questions about their care experiences. Two independent coders blinded to patients' treatment group coded three aspects of the narratives provided by the patients' responses: Themes, Emotional valence , and Personal growth (ie, redemption) . Themes were analyzed descriptively to explore possible differences between patients assigned to the interdisciplinary clinic and patients assigned to the usual care setting. Group differences in patients' emotional experiences were assessed, and we examined potential group differences in positive personal growth. Results: Our findings indicate that an interdisciplinary combined clinic approach provides benefits for patients with multiple inflammatory diseases towards the usual setup. Patients experienced benefits on a number of specific quality-of-life themes including acceptance, optimism, disease understanding, personal growth, and better disease control. The narratives of the patients in the interdisciplinary group were significantly more emotionally positive and included more positive personal growth compared to the usual care group. Conclusion: The findings indicate a patient-reported benefit, especially from the holistic approach and cross-specialty combined consultations in an interdisciplinary clinic compared to usual specialized healthcare, which was underscored by narratives highlighting an overall improved quality of life. Keywords: patient-centered healthcare, interdisciplinary care, psoriasis, psoriatic arthritis, axial spondylitis, inflammatory bowel disease, hidradenitis suppurativa The immune-mediated inflammatory diseases (IMIDs) are a group of chronic conditions that involve dysregulation of the immune system and cause inflammation in different organs. IMIDs encompass a broad range of diseases, including axial spondylitis, psoriasis, psoriatic arthritis, Crohn's disease, ulcerative colitis, and hidradenitis suppurativa. Such conditions affect up to approximately 7% of the Western population. 1 IMIDs, although not generally regarded as life-threatening illnesses, can cause substantial repercussions for patients, their relatives, and society as a whole, especially when patients have several concomitant conditions. These conditions can significantly affect the health-related quality of life (HRQoL) of patients and their family members, resulting in a significant impact on their lives. Patients with IMIDs may experience a number of disease-specific symptoms such as chronic pain, fatigue, physical limitations, itch, and reduced mobility, leading directly to impairment of HRQoL. 2–4 Moreover, IMIDs can cause depression, anxiety, and social isolation, further exacerbating the negative impact on HRQoL. 5–7 IMIDs may also have a significant socioeconomic impact: Patients with IMIDs often require frequent medical appointments, medications, specialized testing, and sometimes hospitalization, leading to increased healthcare utilization and costs. Moreover, IMIDs can cause disability -Abstract Truncated-
health care sciences & services